Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefditoren in COVID-19 Patients With Mild to Moderate Pneumonia
NCT04709172Phase 4Completed
- Sponsor
- Meiji Holdings Co., Ltd.
- Start
- Jan 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefditoren in bacterial pneumonia, sponsored by Meiji Holdings Co., Ltd.. Started Jan 2021; status: completed.
02
Drugs
cefditoren
03
Conditions
bacterial pneumonia
Beyond the preview
Go deeper on NCT04709172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709172.